Form 4 Exponent Inc: Richard Reiss (Group Vice President) For: 3 November
This article reports on a Form 4 filing for Exponent Inc, detailing a transaction by Richard Reiss, a Group Vice President, on November 3. Form 4 filings are regulatory documents that disclose changes in ownership of company stock by insiders. The article indicates a publication date of November 4, 2026, at 01:06 p.m.
Exponent group vice president Richard Reiss sells $110,643 in stock By Investing.com
Richard Reiss, Group Vice President at Exponent Inc. (NASDAQ:EXPO), sold 1,280 shares of the company's common stock for $110,643 on November 3, 2026. Following this transaction, Reiss directly holds 1,008 shares. The sale occurred while Exponent shares traded near their 52-week high, and the company recently reported stronger-than-expected third-quarter earnings.
Form 4 Exponent Inc: Richard Reiss (Group Vice President) For: 3 November
This article reports on a Form 4 filing for Exponent Inc, indicating that Richard Reiss, a Group Vice President, made a transaction on November 3. The filing was published on November 4, 2026, at 18:06.
After selling 1,280 shares, Exponent (EXPO) VP Richard Reiss holds 1,008 directly.
Exponent Inc. Group Vice President Richard Reiss sold 1,280 shares of common stock on November 3, 2026, at $86.44 per share, leaving him with 1,008 shares held directly. This transaction was an open-market or private sale, and no Rule 10b5-1 plan was reported. The SEC filing for this insider trading activity was accepted on November 4, 2026.
Exponent Jumps 6.8% After UBS Maintains Neutral
Exponent, Inc. surged 6.8% after UBS and JP Morgan both raised their price targets on the stock, with an average new target of $91 representing 12.3% upside. UBS maintained a Neutral rating while JP Morgan reiterated an Overweight rating. The bullish analyst action reflects growing confidence in Exponent’s business trajectory and signals a broader reassessment of the company’s market position.
Exponent, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Exponent, Inc. recently exceeded analyst forecasts, leading to updated predictions from analysts. This positive performance suggests a potential shift in sentiment and future expectations for the company's financial outlook. Investors will likely watch how these revised forecasts impact the stock's performance going forward.
Precision Trading with Exponent Inc. (EXPO) Risk Zones
This article provides a detailed analysis of Exponent Inc. (EXPO) using AI-generated trading strategies and multi-timeframe signal analysis. It highlights strong near and mid-term sentiment, identifies potential upside due to a lack of resistance above the current price, and offers specific entry/target/stop-loss zones for position, momentum breakout, and risk hedging strategies.
What Exponent (EXPO) Said on Its Q3 Earnings Call
Exponent (EXPO) reported strong Q3 2026 results, with revenue up 18% and EPS up 16%, driven by high demand for its engineering and scientific consulting services, especially in user research, product safety, failure analysis, and dispute-related work. The company saw increased utilization and growth in both its engineering and environmental segments, with artificial intelligence directly influencing 15% to 20% of its business. Exponent also raised its full-year 2026 outlook, projecting continued revenue and EBITDA margin growth.
Exponent Inc stock hits 52-week high at 82.0 USD By Investing.com
Exponent Inc's stock reached a 52-week high of $81.95, driven by a 19.3% total return over the past year and an 18.2% gain in the last six months. Despite appearing overvalued, management's aggressive share buybacks signal confidence, supported by stronger-than-expected Q3 2026 earnings with diluted EPS of $0.64 and an 18% year-over-year revenue increase to $173.7 million.
Exponent Q3 2026 Earnings Call Transcript
Exponent Inc. reported strong Q3 2026 results with an 18% increase in total revenues and a 10% rise in net income, driven by demand for engineering and scientific expertise, particularly in user research, disputes, and product safety. AI-related work now constitutes 15-20% of the business, with growing inquiries into AI system evaluations and real-world performance. The company raised its full-year guidance for net revenue growth to 10-11% and is intensifying recruiting efforts to meet increasing demand across various specialized fields.
Exponent, Inc. (EXPO) Tops Q3 EPS by 4c; offers outlook
Exponent, Inc. (EXPO) reported strong Q3 results, with EPS of $0.64, beating analyst estimates by $0.04, and revenue of $173.7 million, significantly exceeding the consensus. The company also provided an optimistic outlook for the fourth quarter and the full fiscal year 2026, anticipating robust revenue growth and EBITDA percentages.
Earnings call transcript: Exponent tops Q3 2026 EPS views as growth stays strong
Exponent (EXPO) reported stronger-than-expected Q3 2026 earnings, with diluted EPS of $0.64 against a forecast of $0.5961, and revenue increasing 18% year-over-year to $173.7 million. The company's utilization rate reached 76.7%, its highest in several years, driven by broad-based demand, particularly in user research, product safety, and AI-related work. Management raised its full-year 2026 guidance for net revenue growth and EBITDA margin, anticipating continued strong performance despite a seasonally softer Q4.
Exponent (EXPO) Stock May Be 37% Undervalued On Cash Flow Outlook
Exponent's stock may be 37% undervalued based on a Discounted Cash Flow (DCF) model, suggesting its intrinsic worth is substantially above the current share price of US$77.43. While the stock has fallen 28.0% over the past five years, the analysis focuses on the company's ability to generate reliable free cash flows. The DCF model projects growing free cash flows over the next decade, indicating a potential undervaluation for the specialist consulting firm.
Exponent, Inc. Estimates – NASDAQ:EXPO
This page provides financial actuals and analyst estimates for Exponent, Inc. (NASDAQ:EXPO). Users can explore reported financial data and compare actual results with average, high, and low estimates across income statements, balance sheets, cash flow statements, and valuation metrics. The platform visualizes trends over time for annual and quarterly data.
Argus raised target to USD 75 for Exponent stock
Argus has raised its price target for Exponent (EXPO) to USD 75.00, providing a new valuation marker ahead of the consulting company's third-quarter 2026 results, which are expected on October 29, 2026. Exponent reported second-quarter 2026 revenue of USD 171.61 million and diluted earnings per share of USD 0.60. The current Nasdaq share price is USD 72.56, placing the new target 3.36% above it.
Is Exponent (EXPO) Stock Outpacing Its Business Services Peers This Year?
Exponent (EXPO) stock is outperforming its Business Services peers this year, with a 3.4% year-to-date gain while the sector lost 10.3%. The company holds a Zacks Rank #2 (Buy), indicating strong analyst sentiment and an improving earnings outlook. Another stock, NTT (NTTYY), also shows strong performance with a 9.8% year-to-date return and a Zacks Rank #1 (Strong Buy).
Exponent grows second-quarter revenue 12.00 percent. Exponent stock has a 32.22 P/ E
Exponent (EXPO) reported a 12.00% increase in second-quarter revenue to USD 171.61 million, with adjusted earnings per share of USD 0.60, exceeding expectations. The company's stock has a P/E ratio of 32.22, and it plans to release third-quarter results on October 29, 2026.
Madras High Court Sets Aside Refusal To Register Exponent Energy's 'EXPONENT' Trademark
The Madras High Court has overturned the Trade Marks Registry's decision to deny Exponent Energy Private Limited the registration of "EXPONENT" as a word mark. The court found that the Registrar failed to adequately explain potential confusion and did not consider a statutory exception under the Trade Marks Act, 1999. The application has been remitted to the Registrar for reconsideration within three months, with instructions to separately examine cited marks and assess the evidence of use.
Exponent reports October 29 results for Exponent stock
Exponent (EXPO) will report its third-quarter fiscal 2026 results after market close on October 29, 2026. The company's fiscal year 2025 revenue was $582 million with earnings per share of $2.07. As of October 15, 2026, Exponent's stock was trading at EUR 64.51 on Lang & Schwarz and USD 72.28 on Nasdaq, with a market capitalization of $3.4 billion.
Exponent to Announce Third Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on October 29, 2026
Exponent, Inc. (Nasdaq: EXPO) announced it will report its third-quarter fiscal year 2026 financial results on Thursday, October 29, 2026, after the market closes. The company will host a conference call and webcast at 4:30 p.m. ET to discuss the results and business. Details for accessing the live call and webcast replay are provided.
Exponent, Inc. (EXPO) Stock forecasts
This article is a placeholder for stock forecasts for Exponent, Inc. (EXPO). It currently shows an error in retrieving data and appears to be an incomplete or placeholder page from Yahoo Finance.
Exponent to Announce Third Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on October 29, 2026
Exponent, Inc. (Nasdaq: EXPO) announced it will report its third-quarter fiscal year 2026 financial results on Thursday, October 29, 2026, after market close. Following the announcement, the company's CEO, President, EVP, and CFO will host a conference call and webcast at 4:30 p.m. ET to discuss the business and financial performance. A live and archived webcast will be available on the company's investor relations website, and a telephonic replay will be accessible until November 5, 2026.
Exponent to Announce Third Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on October 29, 2026
Exponent (NASDAQ: EXPO) is scheduled to announce its financial results for the third quarter of fiscal year 2026 on Thursday, October 29, 2026, after the close of market. Following the release, the company will host a conference call at 4:30 p.m. ET to discuss the results. Interested parties can access the webcast and related materials via the investor relations section of Exponent's website.
Exponent stock fell 3.72 percent on October 2
Exponent's stock fell 3.72% on October 2, 2026, closing at USD 67.30 on Nasdaq. This drop occurred despite a strong Q2 fiscal year 2026 performance, where net revenue rose 12% and diluted EPS increased by 15%, driven by demand related to AI, autonomous vehicles, and other technology sectors. Analysts have set an average price target of USD 81.00, indicating a potential upside for the stock.
Exponent Jumps 6.5% Amid Sector-Wide Rally
Exponent (EXPO) saw a 6.5% increase in its stock price, closing at $69.67, as part of a sector-wide rally that benefited professional services and consulting firms. This surge, accompanied by similar gains in peer companies like INOD, HURN, and FCN, suggests a broad revaluation or institutional repositioning in the engineering and technical consulting sector rather than company-specific news. Investors are advised to monitor whether this sector strength persists and to look for further commentary from management regarding demand trends.
Exponent Jumps 6.5% Amid Sector-Wide Rally
Exponent (EXPO) saw its stock surge by 6.5% to $69.67, driven by a sector-wide rally that also benefited other professional services and consulting firms. This broad upward movement, accompanied by high trading volume, suggests a significant revaluation or rotation of investor interest into the engineering, scientific analysis, and technical consulting sectors. The gains appear to be market-driven rather than company-specific, indicating renewed investor appetite for the industry.
Exponent, Inc. (EXPO) Stock Price, News, Quote & History
This article provides an overview of Exponent, Inc. (EXPO) stock, including its current price, market data, and company profile. It details the company's consulting services in science and engineering, financial performance, and analyst insights. Key financial metrics, recent news, and performance against the S&P 500 are also presented.
Live demos put robotics, energy storage and transportation on display at Exponent.
Exponent (EXPO) recently hosted an Investor Day at its Phoenix Test and Engineering Center, featuring presentations and live demonstrations of its research capabilities. The event highlighted the company's growth opportunities driven by artificial intelligence, data center infrastructure, and escalating risks in the energy sector. CEO Dr. Catherine Corrigan emphasized Exponent's unique multidisciplinary approach to solving complex scientific and engineering challenges, particularly as AI expands the need for their expertise.
Exponent stock reports stronger Q2 revenue and EPS
Exponent reported stronger-than-expected Q2 2026 results, with total revenue rising 21.00% to USD 171.6 million and net revenue up 12.00% to USD 148.9 million. Diluted EPS increased 15.00% to USD 0.60. Management attributed the demand to user research for AI-enabled products and reiterated full-year 2026 guidance for net revenue growth of 9.00% to 10.00%. JPMorgan maintained an overweight rating and a price target of USD 90.00, significantly above the current market price.
Form 4 Exponent Inc For: 27 September By Investing.com
This article briefly reports on a Form 4 filing for Exponent Inc. (EXPO) on September 27. Form 4 filings are used to report changes in beneficial ownership of a company's stock by insiders. The article does not provide specific details about the transaction but indicates it was published by Investing.com.
Exponent group VP Souri buys $12,593 in EXPO common stock
Souri Shukri Jeries, Group Vice President at Exponent Inc. (NASDAQ:EXPO), recently acquired 184 shares of the company's common stock for $12,593 through a Dividend Reinvestment Plan. This transaction increases Souri's direct holdings to 40,873 shares and follows Exponent's strong Q2 2026 results and 13 consecutive years of dividend increases. The company's stock is currently trading at $64.18 and is considered undervalued according to InvestingPro analysis.
Exponent (NASDAQ: EXPO) VP adds to 40,873-share stake
Exponent Inc.'s Group Vice President, Shukri Jeries Souri, increased his direct holdings by purchasing 184 shares of common stock at $68.4452 per share through the company's Dividend Reinvestment Plan on September 18, 2026. This transaction brings his total directly held shares to 40,873, in addition to fractional shares acquired via DRIP. The insider trade was reported via a Form 4 filing and is considered a neutral impact with positive sentiment.
Exponent stock trades at USD 68.30 as earnings growth sets the benchmark
Exponent Inc. (EXPO) stock closed at USD 68.30 on September 21, 2026, on Nasdaq, with a market capitalization of approximately USD 3.1 billion. The company reported quarterly revenue of USD 180.4 million and earnings per share of USD 0.50. The article highlights that for a consulting services company, revenue growth and earnings conversion are key operating measures for investors to evaluate against the current valuation.
Exponent (EXPO) details group VP's equity stake
Exponent Inc. (EXPO) Group Vice President Souri Shukri Jeries has reported initial equity holdings, including 40,689 shares of common stock and various restricted stock unit awards. These RSUs are convertible into common stock on a 1-for-1 basis, with expiration dates ranging from March 2027 to March 2030. The filing, a Form 3, details direct ownership and does not include any purchase or sale transactions.
(EXPO) and the Role of Price-Sensitive Allocations
This article provides a quantitative analysis of Exponent Inc. (NASDAQ: EXPO), highlighting strong near and mid-term sentiment but a weak long-term outlook. It presents AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, support, and resistance levels for the stock. The analysis suggests compelling upside potential due to the absence of resistance levels above the current price.
Exponent (EXPO) Rebound Puts Its Growth Narrative And Valuation Back In Focus
Exponent (EXPO) has seen a recent rebound in its share price, with a 22.52% return over the past 90 days. The article explores the valuation gap, noting that while the company is considered 14.4% undervalued with a fair value of $81.67, its current P/E ratio of 29.7x is above both its estimated fair ratio and peer average. This suggests a mix of optimism due to growth prospects in AI safety and advanced medical technologies, and caution due to flat revenues and declining utilization.
Exponent CEO Catherine Corrigan sells $113,135 in EXPO shares
Exponent CEO Catherine Corrigan sold 1,707 shares of EXPO worth $113,135 to cover stock option exercise costs and taxes, while simultaneously exercising non-qualified stock options for 2,379 shares valued at $69,109. Following these transactions, she directly holds 129,108 shares. The company recently reported strong Q2 2026 results, surpassing expectations, and raised its full-year outlook.
Exponent CEO Catherine Corrigan sells $113,135 in EXPO shares
Exponent CEO Catherine Corrigan sold 1,707 shares of EXPO stock for $113,135 to cover stock option exercise costs and taxes, while simultaneously exercising options to acquire 2,379 shares. Post-transaction, she directly holds 129,108 shares. This comes after Exponent reported strong Q2 2026 results, exceeding expectations and raising its full-year outlook.
Exponent CEO Catherine Corrigan disposes of 1,707 shares worth $113,144 in Exponent stock
Exponent CEO Catherine Corrigan sold 1,707 shares of Exponent stock for $113,144 on August 17, after exercising non-qualified stock options for 2,379 shares at $29.05 on the same day. This transaction leaves her with 129,108 shares owned in the company. The information was generated by AI based on an EDGAR filing from Exponent Inc.
Exponent (NASDAQ: EXPO) CEO trades shares tied to option exercise
Exponent Inc. (NASDAQ: EXPO) CEO Catherine Corrigan exercised 2,379 non-qualified stock options at $29.05 per share and subsequently sold 1,707 common shares at $66.2776 per share. The sale, conducted under a Rule 10b5-1 trading plan, was intended to cover the option exercise price and associated taxes. Following these transactions, Corrigan holds 129,108 common shares directly.
Exponent CEO Catherine Corrigan disposes of 1,707 shares worth $113,144 in Exponent stock
Exponent CEO Catherine Corrigan sold 1,707 shares of Exponent stock for $113,144 on August 17. Earlier, she exercised non-qualified stock options for 2,379 shares. After these transactions, she retains 129,108 shares in the company.
Exponent (NASDAQ: EXPO) insider to sell 1,707 shares
An insider at Exponent, Inc. (EXPO) plans to sell 1,707 shares of common stock, stemming from an exercise of stock options on August 17, 2026. The transaction will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services and has an aggregate value of $114,539.70. This filing also references prior 10b5-1 sales by Catherine Corrigan in June and July 2026.
ETFs Investing in Exponent, Inc. Stocks
This article provides a comprehensive list of Exchange Traded Funds (ETFs) that hold Exponent, Inc. stocks, sorted by market value. It details various ETFs, including their market value, weight of Exponent, Inc. stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, and 3-year NAV total return. The information aims to help investors explore opportunities to invest in Exponent, Inc. indirectly through diversified ETF portfolios.
Assenagon Asset Management S.A. Makes New $2.31 Million Investment in Exponent, Inc. $EXPO
Assenagon Asset Management S.A. has initiated a new position in Exponent, Inc. (NASDAQ:EXPO), investing approximately $2.31 million by purchasing 39,342 shares. Exponent recently exceeded quarterly earnings expectations with $0.60 EPS on $171.61 million revenue, and declared a quarterly dividend of $0.31 per share. The stock currently holds a "Moderate Buy" consensus rating from analysts with an average price target of $81.
Exponent Inc (EXPO) Earnings Forecast: Future EPS & Revenue Growth Estimates
Exponent Inc (EXPO) has an earnings forecast score of 8.00, placing it 38th in its industry. Analysts have set an average price target of $83.00, with a high of $90.00 and a low of $76.00, predominantly recommending a "Buy" for the stock. The company's expected revenue for the next quarter is $152.69 million, and its EPS for the next quarter is projected to be $0.59.
Quantinno Capital Management LP Acquires 19,528 Shares of Exponent, Inc. $EXPO
Quantinno Capital Management LP significantly increased its stake in Exponent, Inc. (NASDAQ:EXPO) by 114.3% in Q1, purchasing 19,528 additional shares, bringing its total holding to $2.39 million. Other institutional investors also adjusted their positions in Exponent, a company with strong institutional ownership (92.37%). Exponent reported solid Q1 earnings, exceeding estimates with $0.60 EPS and 12% year-over-year revenue growth, and declared a quarterly dividend of $0.31 per share.
Exponent, Inc. (EXPO) Stock Forecasts
Argus has raised its target price for Exponent, Inc. (EXPO), a science and engineering consulting firm, to $71.00. The report highlights Exponent's team of scientists, physicians, engineers, and business consultants who provide solutions to complex problems. The current stock price for EXPO is $67.52.
Exponent (EXPO) Q2 2026 Earnings Call Transcript
Exponent (EXPO) reported strong Q2 2026 results with double-digit growth in revenues and earnings, driven by increased demand for specialized expertise, particularly in user research studies for AI-enabled products and risk management in the utility sector. The company raised its full-year 2026 revenue and EBITDA guidance, reflecting confidence in ongoing market trends and project expansion. Exponent also actively repurchased shares and highlighted its competitive advantage in multidisciplinary scientific and engineering consulting for complex, high-consequence challenges.
How Investors May Respond To Exponent (EXPO) Upgraded 2026 Guidance And Expanded Buyback Plan
Exponent (EXPO) recently reported strong Q2 2026 results with year-on-year growth in sales, revenue, and net income, along with a dividend declaration and share repurchase completion. The company also upgraded its 2026 revenue growth guidance to 9-10% and expanded its share buyback authorization by US$50 million to US$836.7 million. This signals management's confidence and continued focus on capital return, although investors should remain aware of potential risks like utilization and staffing efficiency.
How Investors May Respond To Exponent (EXPO) Upgraded 2026 Guidance And Expanded Buyback Plan
Exponent, Inc. recently reported strong Q2 2026 results, showing significant year-on-year growth in sales, revenue, and net income, along with a dividend declaration and share repurchase completion. The company also upgraded its 2026 revenue growth guidance to 9% to 10% and expanded its share buyback authorization, indicating management's confidence and focus on capital returns. This upgraded guidance is expected to influence the investment narrative around Exponent's growth and resilience, despite ongoing risks related to utilization and workforce efficiency.